Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > News After The Close

<< Previous

Bullboard Posts

Next >>

Comment by riverrrowon Sep 25, 2024 9:54pm

118 Views

Post# 36241444

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:News After The Close

The insiders will have to pay 25 cents to exercise these options whereas a handful of investors just picked up a bunch of shares at 20 cents in the pp that just closed. And the insiders don't dare sell their shares unless the company gets bought out, otherwise they suffer the wrath of some lividly jealous shareholders. GLTA.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario